m m m m m m m m m m
arch all chapters
m m
Advanced Health Assessment (Walden University)
m m m m
, TestmBank mfor mFocusmOnmNursingmPharmacologym7thmEd
ition
Chapterm1:mIntroduction mto mDrugs
CognitivemLevel:m ApplicationmDiffic
ulty:m Moderate
Integrated mProcess:m Nursingmprocess
1.A mnursemworkingminmradiologymadministersmiodinemtomampatient mwhomismhavingmamco
mputerized maxialmtomographym(CAT)mscan.mA mnursemworkingmon manmoncology munit m
administersmchemotherapymtompatientsmwhomhavemcancer.mAt mthemPublicmHealthmDep
artment,mamnursemadministersmammeasles-mumps-rubellam(MMR)mvaccinemtomam14-
mmonth-
old mchild masmamroutinemimmunization.mWhichmbranchmof mpharmacologymbest mdescrib
esmthemactionsmof mallmthreemnurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
Ans: B
Response:
Pharmacologymismthemstudymof mthembiologicmeffectsmof mchemicals.mNursesmareminvolve
d mwithmclinicalmpharmacologymormpharmacotherapeutics,mwhichm isma mbranchmof mpharm
acologymthat mdealsmwithmthemusesmof mdrugsmtomtreat,mprevent,mand mdiagnosemdisease.mT
hemnursemworkingminmradiologymismadministeringmamdrugmtomhelpmdiagnosema mdisease.mT
hemnursemworkingmonmanmoncologymunit mismadministeringmamdrugmtomhelpmtreat mamdiseas
e.mPharmacoeconomicsmincludesmanymcostsminvolved minmdrugmtherapy.
Pharmacodynamicsminvolvesmhowmamdrugmaffectsmthembody,mand mpharmacokineticsmism
how mthembodymactsmonmthemdrug.
CognitivemLevel:m ComprehensionmD
ifficulty:m Easy
Integrated mProcess:m Nursingmprocess
2.A mphysicianmhasmordered mintramuscularminjectionsmof mmorphine,ma mnarcotic,meverym4mh
oursmasmneeded mformpainmformammotormvehiclemaccident mvictim.mThemnursemismawaremthat
mtheremismamhighmabusempotentialmformthismdrug;mtherefore,mmorphinemis mcategorized masm
a:
A) SchedulemI mdrug
B) SchedulemII mdrug
C) SchedulemIII mdrug
D) SchedulemIVmdrug
Ans: B
Response:
Narcoticsmsuchmasmmorphinemaremconsidered mschedulemII mdrugsmbecausemof mthemhighma
busempotentialmwithmseveremdependencemliability.mSchedulemI mdrugsmhavemhighmabusemp
otentialmand mnomaccepted mmedicalmuse.mSchedulemIII mdrugsmhavemamlessermabusempotent
ialmthanmschedulemII mdrugsmand manmaccepted mmedicalmuse.mSchedulemIVmdrugsmhavemlo
wmabusempotentialmand mlimited mdependencemliability.
CognitivemLevel:m Comprehensionm
Difficulty:m Easy
Integrated mProcess:m Communicationmand mdocumentation
3.A mnursemworkingmformamdrugmcompanymisminvolved minmphasemIII mdrugmevaluationmstudi
es.mWhichmof mthemfollowingmmight mthemnursembemresponsiblemformduringmthismstagemof m
drugmdevelopment?
Pagem1
, TestmBank mfor mFocusmOnmNursingmPharmacologym7thmEd
ition
Chapterm1:mIntroduction mto mDrugs
A) Workingmwithmanimalsmwhomaremgivenmexperimentalmdrugs
B) Monitoringmdrugmeffectsminmpatientsmwhomaremselected mtomparticipateminmamstudy,
mwhomhavemthemdiseasemthat mthemdrugmismmeant mtomtreat
C) Collectingmrecordsmof msymptomsmthat mparticipantsmexperiencemwhilemtakingmamd
rugmand mdeterminingmwhethermtheymaremcaused mbymthemdiseasemormthemdrugmInfo
D) rmingmhealthy,myoungmvolunteermparticipantsmof mpossiblemrisksmthat mcould moccur
mfrommtakingmanmexperimentalmdrug
Ans: C
Response:
PhasemIII mstudiesminvolvemusemof mamdrugminmamvast mclinicalmmarket mwherempatientsmarem
asked mtomrecord manymsymptomsmtheymexperiencemwhilemtakingmthemdrugs.mNursesmmaym
bemresponsiblemformhelpingmcollect mand manalyzemtheminformationmtombemshared mwithmth
em Food mand mDrugmAdministrationm(FDA).mUsemof manimalsminmdrugmtestingmismdoneminm
thempreclinicalmtrials.mAmselect mgroupmof mpatientsmwhomareminvolved minmphasemII mstudie
smparticipateminmstudiesmwheremthemparticipantsmhavemthemdiseasemthemdrugmismintended m
tomtreat.mThesempatientsmaremmonitored mcloselymformdrugmeffects.mPhasemI mstudiesminvol
vemhealthymhumanmvolunteersmwhomaremusuallympaid mformtheirmparticipation.mNursesmm
aymobservemformadversemeffectsmand mtoxicity.
CognitivemLevel:m ComprehensionmD
ifficulty:m Moderate
Integrated mProcess:m NursingmProcess
4. Whichmof mthemfollowingmconceptsmismconsidered mwhenmgenericmdrugsmaremsubstituted mf
ormbrand-namemdrugs?
A) Bioavailability
B) Criticalmconcentration
C) Distribution
D) Half-life
Ans: A
Response:
Bioavailabilitymismthemportionmof mamdosemof mamdrugmthat mreachesmthemsystemicmcirculati
onmand mismavailablemtomact monmbodymcells.mBindersmused minmamgenericmdrugmmaymnot mbe
mthemsamemasmthosemused minmthembrand-
namemdrug.mTherefore,mthemwaymthembodymbreaksmdownmand musesmthemdrugmmaymdiffer,
mwhichmmaymeliminatemamsubstitution.mCriticalmconcentrationmis mthemamount mof mamdrugm
that mismneeded mtomcausemamtherapeuticmeffect.
Distributionmismthemphasemof mpharmacokineticsmthat minvolvesmthemmovement mof mamdrug
mtomthembody'smtissues.mA mdrug'smhalf-
lifemismthemtimemit mtakesmformthemamount mof mdrugmtomdecreasemtomone-
half mof mthempeakmlevel.
CognitivemLevel:m AnalysismDifficu
lty:m Difficult
Integrated mProcess:m Teaching/learning
A) 5.A mnursemismteachingmhermpatient mabout mthemusemof mover-the-
counterm(OTC)mdrugs.mWhichmof mthemfollowingmstatementsmbest minformsmthempatient ma
B) bout mtheirmsafemuse?
“OTCmdrugsmaremproductsmthat maremavailablemwithout mprescriptionmformself-
mtreatment mof mminormcomplaints.”
“OTCmdrugsmaremconsidered mmedicationsmand mshould mbemreported monmamdrugmhis
Pagem2
, TestmBank mfor mFocusmOnmNursingmPharmacologym7thmEd
ition
t
o
r
y
.
”
Pagem3